Chimerix, Inc. News Releases http://ir.chimerix.com/ Chimerix, Inc. News Releases en Chimerix Announces First Quarter 2019 Financial Results and Strategy Update http://ir.chimerix.com/news-releases/news-release-details/chimerix-announces-first-quarter-2019-financial-results-and – Reports Positive Top-line Survival Data from Pivotal Mouse Study as Key Milestone on Path to Smallpox Regulatory Submission – – Plan to Focus on Execution of Smallpox Program, Halting All Other Brincidofovir Development Activities – – Restructuring to Reduce Workforce by More Than 50%, Thu, 09 May 2019 08:00:00 -0400 Chimerix, Inc. News Releases 12111 Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019 http://ir.chimerix.com/news-releases/news-release-details/chimerix-announce-first-quarter-2019-financial-results-may-9 DURHAM, N.C. , May 02, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a live conference call and audio webcast on Thursday, May 9, 2019 at 8:30 a.m. Thu, 02 May 2019 16:01:00 -0400 Chimerix, Inc. News Releases 12101 Chimerix Announces Management Updates http://ir.chimerix.com/news-releases/news-release-details/chimerix-announces-management-updates Mike Sherman Appointed Chief Executive Officer and Mike Andriole Appointed Chief Business Officer DURHAM, N.C. , April 08, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announces the appointment of Mon, 08 Apr 2019 17:00:00 -0400 Chimerix, Inc. News Releases 12051 Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results http://ir.chimerix.com/news-releases/news-release-details/chimerix-announces-fourth-quarter-and-full-year-2018-financial – Reports Positive Preliminary Top-line Data from Second Rabbitpox Study – – Type C Meeting Requested with FDA Regarding Virologic Endpoint – – Conference Call at 8:30 a.m. ET Today – DURHAM, N.C. , March 05, 2019 (GLOBE NEWSWIRE) -- Chimerix  (NASDAQ:CMRX), a biopharmaceutical company developing Tue, 05 Mar 2019 07:00:00 -0500 Chimerix, Inc. News Releases 12011 Chimerix to Present at Cowen and Company 39th Annual Health Care Conference http://ir.chimerix.com/news-releases/news-release-details/chimerix-present-cowen-and-company-39th-annual-health-care DURHAM, N.C. , March 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that Timothy Trost , Chief Financial Officer of Chimerix, will present at the Cowen and Company 39th Annual Mon, 04 Mar 2019 08:00:00 -0500 Chimerix, Inc. News Releases 12001 Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019 http://ir.chimerix.com/news-releases/news-release-details/chimerix-announce-fourth-quarter-and-full-year-2018-financial DURHAM, N.C. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a live conference call and audio webcast on Tuesday, March 5, 2019 at 8:30 a.m. Tue, 26 Feb 2019 08:00:00 -0500 Chimerix, Inc. News Releases 11981 Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study http://ir.chimerix.com/news-releases/news-release-details/chimerix-presents-results-post-hoc-analysis-phase-3-study Decreased HHV-6 Reactivation Observed Among Oral Brincidofovir Allogeneic Hematopoietic Cell Transplantation Recipients Results to be Presented at Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR 2019 DURHAM, N.C. , Feb. 22, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a Fri, 22 Feb 2019 08:00:00 -0500 Chimerix, Inc. News Releases 11976 Chimerix Announces Management Transition http://ir.chimerix.com/news-releases/news-release-details/chimerix-announces-management-transition M. Michelle Berrey to Step Down as Chief Executive Officer DURHAM, N.C. , Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Wed, 06 Feb 2019 08:00:00 -0500 Chimerix, Inc. News Releases 11926 Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference http://ir.chimerix.com/news-releases/news-release-details/chimerix-present-37th-annual-jp-morgan-healthcare-conference DURHAM, N.C. , Jan. 04, 2019 (GLOBE NEWSWIRE) -- Chimerix  (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Michelle Berrey , M.D., M.P.H, President and Chief Executive Officer of Chimerix, will present at Fri, 04 Jan 2019 07:30:00 -0500 Chimerix, Inc. News Releases 11876 Chimerix Announces Third Quarter 2018 Financial Results http://ir.chimerix.com/news-releases/news-release-details/chimerix-announces-third-quarter-2018-financial-results - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- Chimerix  (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today reported financial results and provided a corporate update for the third Thu, 08 Nov 2018 07:00:00 -0500 Chimerix, Inc. News Releases 11851